Skip to content
Recall Observatory FDA recall evidence

Drug product

Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-759-01.

D-0242-2025

January 29, 2025

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 96194
Status
Ongoing
Classification
Class II
Quantity
53,952 bottles
Official record key
drug-enforcement:D-0242-2025

Official wording

Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Code information: Lot Numbers: 19234630, Exp.: 10/2025; 19240529, Exp.: 1/2026.

Distribution pattern: Nationwide within the U.S

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso Atomoxetine Impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations